<DOC>
	<DOCNO>NCT02818907</DOCNO>
	<brief_summary>This study aim collect clinical , biological quality life data patient borderline resectable pancreatic cancer . It collect information date diagnosis along therapeutic care patient , 3-years follow-up end treatment . The database update patient 's visit . Biological sample include : tumor , plasma . Epidemiological data also collect , whereas Quality life assess EORTC standard . The objective database identify new biomarkers ( genomic , immunologic , epidemiologic ) promote high quality standard research protocol .</brief_summary>
	<brief_title>Evaluation Survival Prognostic Factors Patients With Exocrine Pancreatic Cancer Resectable Potentially Resectable</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Patients exocrine resectable pancreatic adenocarcinoma potentially resectable ( neoadjuvant treatment consider appropriate candidate resection ) Histologically cytologically document diagnosis exocrine pancreatic adenocarcinoma Written inform consent obtain prior enrollment study type pancreatic cancer , particular endocrine tumor acinar cell ampulloma metastatic disease malignancy within last 5 year , except adequately treat carcinoma situ cervix squamous carcinoma skin , adequately control limited basal cell skin cancer patient medical psychiatric condition disease would make patient inappropriate entry study patient guardianship , curator protection justice .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>